Abstract
Aim:
To determine whether pranlukast, a cysteinyl leukotriene receptor-1 antagonist, exerts an anti-inflammatory effect on focal cerebral ischemia in mice.
Methods:
Focal cerebral ischemia in mice was induced by permanent middle cerebral artery occlusion (MCAO). In addition to neurological deficits, infarct volume, degenerated neurons and endogenous IgG exudation, we detected accumulation of neutrophils and macrophage/microglia in the ischemic brain tissue 72 h after MCAO. Pranlukast was ip injected 30 min before and after MCAO.
Results:
Pranlukast significantly attenuated neurological deficits, infarct volume, neuron degeneration and IgG exudation. Importantly, pranlukast (0.01 and 0.1 mg/kg) inhibited myeloperoxidase-positive neutrophil, but not CD 11b-positive macrophage/microglial accumulation in the ischemic cortical tissue.
Conclusion:
Pranlukast exerts an anti-inflammatory effect on focal cerebral ischemia in the subacute phase that is limited to neutrophil recruitment through the disrupted blood-brain barrier.
Similar content being viewed by others
Article PDF
References
Dirnagl U, Simon RP, Hallenbeck JM . Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 2003; 26: 248–54.
Fagan SC, Hess DC, Hohnadel EJ, Pollock DM, Ergul A . Targets for vascular protection after acute ischemic stroke. Stroke 2004; 35: 2220–5.
Danton GH, Dietrich WD . Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol 2003; 62: 127–36.
Simundic AM, Basic V, Topic E, Demarin V, Vrkic N, Kunovic B, et al. Soluble adhesion molecules in acute ischemic stroke. Clin Invest Med 2004; 27: 86–92.
Gidday JM, Gasche YG, Copin JC, Shah AR, Perez RS, Shapiro SD, et al. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am J Physiol Heart Circ Physiol 2005; 289: H558–68.
Baba T, Black KL, Ikezaki K, Chen KN, Becker DP . Intracarotid infusion of leukotriene C4 selectively increases blood-brain barrier permeability after focal ischemia in rats. J Cereb Blood Flow Metab 1991; 11: 638–43.
Rao AM, Hatcher JF, Kindy MS, Dempsey RJ . Arachidonic acid and leukotriene C4: role in transient cerebral ischemia of gerbils. Neurochem Res 1999; 24: 1225–32.
Ciceri P, Rabuffetti M, Monopoli A, Nicosia S . Production of leukotrienes in a model of focal cerebral ischaemia in the rat. Br J Pharmacol 2001; 133: 1323–9.
Di Gennaro A, Carnini C, Buccellati C, Ballerio R, Zarini S, Fumagalli F, et al. Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: a role for transcellular biosynthesis of cysteinyl-leukotrienes. FASEB J 2004; 18: 842–4.
Nagata M, Saito K, Tsuchiya K, Sakamoto Y . Leukotriene D4 upregulates eosinophil adhesion via the cysteinyl leukotriene 1 receptor. J Allergy Clin Immunol 2002; 109: 676–80.
Nagata M, Saito K, Kikuchi I, Hagiwara K, Kanazawa M . Effect of the cysteinyl leukotriene antagonist pranlukast on transendothelial migration of eosinophils. Int Arch Allergy Immunol 2005; 137: S2–6.
Nagata M, Saito K . The roles of cysteinyl leukotrienes in eosinophilic inflammation of asthmatic airways. Int Arch Allergy Immunol 2003; 131: S7–10.
Brink C, Dahlen SE, Drazen J, Evans JF, Hay DW, Nicosia S, et al. International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors. Pharmacol Rev 2003; 55: 195–227.
Sarau HM, Ames RS, Chambers J, Ellis C, Elshourbagy N, Foley JJ, et al. Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. Mol Pharmacol 1999; 56: 657–63.
Zhang WP, Hu H, Zhang L, Ding W, Yao HT, Chen KD, et al. Expression of cysteinyl leukotriene receptor 1 in human traumatic brain injury and brain tumors. Neurosci Lett 2004; 363: 247–51.
Zeng LH, Zhang WP, Wang RD, Wang PL, Wei EQ . Protective effect of ONO-1078, a leukotriene antagonist, on focal cerebral ischemia in mice. Yao Xue Xue Bao 2001; 36: 148–50. Chinese.
Zhang WP, Wei EQ, Mei RH, Zhu CY, Zhao MH . Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia in rats. Acta Pharmacol Sin 2002; 23: 871–7.
Zhang LH, Wei EQ . Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on transient global cerebral ischemia in rats. Acta Pharmacol Sin 2003; 24: 1241–7.
Zhang SH, Wei EQ, Zhu CY, Chen Z, Zhang SF . Protective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia induced by endothelin-1 in rats. Yao Xue Xue Bao 2004; 39: 1–4. Chinese.
Yu GL, Wei EQ, Zhang SH, Xu HM, Chu LS, Zhang WP, et al. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose-and time-dependently protects against focal cerebral ischemia in mice. Pharmacology 2005; 73: 31–40.
Yu GL, Wei EQ, Wang ML, Zhang WP, Zhang SH, Weng JQ, et al. Pranlukast, a cysteinyl leukotriene receptor-1 antagonist, protects against chronic ischemic brain injury and inhibits the glial scar formation in mice. Brain Res 2005; 1053: 116–25.
Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H . Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986; 17: 472–6.
Schmued LC, Hopkins KJ . Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 2000; 874: 123–30.
Yang GY, Liu XH, Kadoya C, Zhao YJ, Mao Y, Davidson BL, et al. Attenuation of ischemic inflammatory response in mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist. J Cereb Blood Flow Metab 1998; 18: 840–7.
Sedgwick JD, Schwender S, Imrich H, Dorries R, Butcher GW, ter Meulen V . Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc Natl Acad Sci USA 1991; 88: 7438–42.
Jensen MB, Finsen B, Zimmer J . Morphological and immuno-phenotypic microglial changes in the denervated fascia dentata of adult rats: correlation with blood-brain barrier damage and astroglial reactions. Exp Neurol 1997; 143: 103–16.
Schilling M, Besselmann M, Leonhard C, Mueller M, Ringelstein EB, Kiefer R . Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluorescent protein transgenic bone marrow chimeric mice. Exp Neurol 2003; 183: 25–33.
Fukushima C, Matsuse H, Hishikawa Y, Kondo Y, Machida I, Saeki S, et al. Pranlukast, a leukotriene receptor antagonist, inhibits interleukin-5 production via a mechanism distinct from leukotriene receptor antagonism. Int Arch Allergy Immunol 2005; 136: 165–72.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the National Natural Science Foundation of China (No 30271498).
Rights and permissions
About this article
Cite this article
Chu, Ls., Wei, Eq., Yu, Gl. et al. Pranlukast reduces neutrophil but not macrophage/microglial accumulation in brain after focal cerebral ischemia in mice. Acta Pharmacol Sin 27, 282–288 (2006). https://doi.org/10.1111/j.1745-7254.2006.00290.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2006.00290.x
Keywords
This article is cited by
-
Mechanistic insight on the role of leukotriene receptors in ischemic–reperfusion injury
Pharmacological Reports (2021)
-
Peripheral polymorphonuclear leukocyte activation as a systemic inflammatory response in ischemic stroke
Neurological Sciences (2013)
-
Disruption of the alox5ap gene ameliorates focal ischemic stroke: possible consequence of impaired leukotriene biosynthesis
BMC Neuroscience (2012)
-
Aggravated inflammation and increased expression of cysteinyl leukotriene receptors in the brain after focal cerebral ischemia in AQP4-deficient mice
Neuroscience Bulletin (2012)
-
The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia
Journal of Neuroinflammation (2010)